1846 related articles for article (PubMed ID: 15590663)
1. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer's disease mice.
Maiti P; Hall TC; Paladugu L; Kolli N; Learman C; Rossignol J; Dunbar GL
Histochem Cell Biol; 2016 Nov; 146(5):609-625. PubMed ID: 27406082
[TBL] [Abstract][Full Text] [Related]
3. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF
J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930
[TBL] [Abstract][Full Text] [Related]
4. Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology.
Frautschy SA; Hu W; Kim P; Miller SA; Chu T; Harris-White ME; Cole GM
Neurobiol Aging; 2001; 22(6):993-1005. PubMed ID: 11755008
[TBL] [Abstract][Full Text] [Related]
5. Curcuminoid binds to amyloid-β1-42 oligomer and fibril.
Yanagisawa D; Taguchi H; Yamamoto A; Shirai N; Hirao K; Tooyama I
J Alzheimers Dis; 2011; 24 Suppl 2():33-42. PubMed ID: 21335654
[TBL] [Abstract][Full Text] [Related]
6. The interaction of insoluble Amyloid-β with soluble Amyloid-β dimers decreases Amyloid-β plaque numbers.
van Gerresheim EF; Herring A; Gremer L; Müller-Schiffmann A; Keyvani K; Korth C
Neuropathol Appl Neurobiol; 2021 Aug; 47(5):603-610. PubMed ID: 33338256
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Alzheimer's amyloid toxicity with a tricyclic pyrone molecule in vitro and in vivo.
Hong HS; Rana S; Barrigan L; Shi A; Zhang Y; Zhou F; Jin LW; Hua DH
J Neurochem; 2009 Feb; 108(4):1097-1108. PubMed ID: 19141069
[TBL] [Abstract][Full Text] [Related]
8. Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin.
Maiti P; Plemmons A; Bowers Z; Weaver C; Dunbar G
J Vis Exp; 2019 Nov; (153):. PubMed ID: 31736502
[TBL] [Abstract][Full Text] [Related]
9. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer's disease brains: Implications for in-vivo diagnostics.
den Haan J; Morrema THJ; Rozemuller AJ; Bouwman FH; Hoozemans JJM
Acta Neuropathol Commun; 2018 Aug; 6(1):75. PubMed ID: 30092839
[TBL] [Abstract][Full Text] [Related]
10. Iron treatment inhibits Aβ42 deposition in vivo and reduces Aβ42/Aβ40 ratio.
Shen X; Liu J; Fujita Y; Liu S; Maeda T; Kikuchi K; Obara T; Takebe A; Sayama R; Takahashi T; Matsue A; Sera K; Michikawa M; Komano H; Zou K
Biochem Biophys Res Commun; 2019 May; 512(4):653-658. PubMed ID: 30791980
[TBL] [Abstract][Full Text] [Related]
11. Fluorine-19 Magnetic Resonance Imaging for Detection of Amyloid β Oligomers Using a Keto Form of Curcumin Derivative in a Mouse Model of Alzheimer's Disease.
Yanagisawa D; Ibrahim NF; Taguchi H; Morikawa S; Tomiyama T; Tooyama I
Molecules; 2021 Mar; 26(5):. PubMed ID: 33806326
[TBL] [Abstract][Full Text] [Related]
12. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
Song Y; Kim HD; Lee MK; Hong IH; Won CK; Bai HW; Lee SS; Lee S; Chung BY; Cho JH
PLoS One; 2017; 12(1):e0169509. PubMed ID: 28072821
[TBL] [Abstract][Full Text] [Related]
13. Nonhuman amyloid oligomer epitope reduces Alzheimer's-like neuropathology in 3xTg-AD transgenic mice.
Rasool S; Martinez-Coria H; Milton S; Glabe CG
Mol Neurobiol; 2013 Dec; 48(3):931-40. PubMed ID: 23771815
[TBL] [Abstract][Full Text] [Related]
14. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide. An in vitro model of preamyloid.
Huang TH; Yang DS; Fraser PE; Chakrabartty A
J Biol Chem; 2000 Nov; 275(46):36436-40. PubMed ID: 10961999
[TBL] [Abstract][Full Text] [Related]
15. Curcumin Binding to Beta Amyloid: A Computational Study.
Rao PP; Mohamed T; Teckwani K; Tin G
Chem Biol Drug Des; 2015 Oct; 86(4):813-20. PubMed ID: 25776887
[TBL] [Abstract][Full Text] [Related]
16. Quinacrine directly dissociates amyloid plaques in the brain of 5XFAD transgenic mouse model of Alzheimer's disease.
Park S; Kim HY; Oh HA; Shin J; Park IW; Yoon S; Woo DH; Kim Y
Sci Rep; 2021 Jun; 11(1):12043. PubMed ID: 34103615
[TBL] [Abstract][Full Text] [Related]
17. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST
FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579
[TBL] [Abstract][Full Text] [Related]
18. A "keto-enol" plaque buster mechanism to diminish Alzheimer's β-Amyloid burden.
Zoltán O; László P; Éva K; Béla V
Biochem Biophys Res Commun; 2020 Oct; 532(1):82-87. PubMed ID: 32828536
[TBL] [Abstract][Full Text] [Related]
19. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.
Lim GP; Chu T; Yang F; Beech W; Frautschy SA; Cole GM
J Neurosci; 2001 Nov; 21(21):8370-7. PubMed ID: 11606625
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of 1-(4-[¹⁸F]fluoroethyl)-7-(4'-methyl)curcumin with improved brain permeability for β-amyloid plaque imaging.
Lee I; Yang J; Lee JH; Choe YS
Bioorg Med Chem Lett; 2011 Oct; 21(19):5765-9. PubMed ID: 21885280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
